Google AI

TMX Newsfile

Vesalius Longevity Labs Commences Trading Today on the Canadian Securities Exchange Under the Symbol "VLAB"

Vancouver, British Columbia and Scottsdale, Arizona--(Newsfile Corp. - November 12, 2026) - Vesalius Longevity Labs Inc.  (CSE: VLAB) ("Vesalius" or the "Company") is pleased to announce that it will commence trading on the

Canadian Securities Exchange ("CSE") under the symbol "VLAB" today, November 12, 2026.

"Today marks an important milestone for Vesalius Labs, and I want to sincerely thank our Board of Directors, our entire team, and our shareholders and stakeholders for their support and guidance throughout our journey so far," said Dr. Pradeep Albert, MD, CEO of Vesalius Labs. "We believe the future is longevity and wellness. As one of the first publicly traded companies in the sector, Vesalius is well positioned to become a leading global brand, backed by science and quality. Peptides are one of the fastest-moving areas in longevity, and we are building the whole path from lab to consumer. That includes Made-in-the-USA peptide APIs under our Peptual® brand, a doctor-led model that connects licensed providers with patients, and AI-powered tools that make care more personalized. Commencing trading on the CSE gives us a strong platform to help accelerate that vision, and we look forward to an exciting road ahead."

Additional information on the Company and the business of Vesalius can be found in the Company's Listing Statement dated November 9, 2026 as filed on SEDAR+ at www.sedarplus.ca.

About Vesalius

Vesalius Longevity Labs (CSE: VLAB), is a longevity science and regenerative health platform focused on being the trusted seed-to-brand partner across the consumer journey for peptide therapeutics, biologics and preventative healthcare. Vesalius operates a scalable B2Doctor2Consumer ecosystem designed to support healthcare providers and telehealth infrastructure. Vesalius will manufacture under its Peptual® brand "Made-in-the-USA" peptide APIs (active pharmaceutical ingredients) for domestic and international compounding supply chains. Vesalius's expanding ecosystem includes regenerative medicine, multi-faceted compounding pharmacy initiatives, biologics partnerships and advanced AI-powered technologies designed to support the future of personalized health and wellness.

Investors interested in learning more about Vesalius Longevity Labs are encouraged to contact the Company at:
https://www.vesaliuslabs.com/

For further information, please refer to the Company's disclosure record on SEDAR+ at www.sedarplus.ca.

On Behalf of the Company

"Pradeep Albert"
Chief Executive Officer

Contact:

Julia Becker
Vice President, Capital Markets
T: +1 (604) 785-0850
E: jbecker@vesaliuslabs.com

The CSE has neither approved nor disapproved the contents of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/323657

More Articles …

  1. Quantropi Enters Vietnam Market Through Strategic Partnership with VNet to Advance Post-Quantum Readiness
  2. TempraMed Granted U.S. Patent for Pen Agnostic, VIVI Cap Smart(TM) Further Strengthens Global Intellectual Property Position
  3. TMX Group Equity Financing Statistics - October 2026
  4. Scandium International Mining Engages Jon Christian Evensen as Strategic Advisor
  5. Graphene Manufacturing Group Ltd. Provides Details of 2026 Annual General Meeting to Be Held Virtually
  6. Doubleview Announces Closing of Final Tranche of Oversubscribed Flow-Through Private Placement
  7. GMG Announces Exclusive G(R) LUBRICANT Distributor in Mexico
  8. NANO Nuclear to Hold Fourth Quarter Business Update Webcast on November 30, 2026
  9. Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community
  10. Increased Budget Supports Drilling of Cookara Target at Nevertire South
  11. Casa Minerals Announces Closing of Third and Final Tranche of Private Placement
  12. Doubleview Announces Closing of Upsized Flow-Through Private Placement
  13. TMX Group Consolidated Trading Statistics - October 2026
  14. Ray Anam Inc. Studios Accelerates Cross-Platform Gaming Expansion Toward Steam, Nintendo Switch, Playstation, and Xbox Following Rapid Mobile Growth
  15. Focus Graphite Secures Canadian Patent for Silicon-Enhanced Graphite Battery Anode Technology
  16. Scalare Partners Launches InHouse Ventures Syndicate Investment Platform, Giving Wholesale Investors Early Access to Australia's Next Generation of Technology Companies
  17. Doubleview Announces $3.2 Million Flow-Through Private Placement
  18. Doubleview Announces Filing of Q2 Financials and Offers Update on Emissary Agreement
  19. Radisson Announces Latest Drill Results Extending High-Grade Gold Mineralization Beneath and Adjacent to the Former O'Brien Gold Mine
  20. Greenbriar Announces General (Ret) Hokanson as CEO
hacklink makrobetesim espagnezlibraryzlibrarynon gamstopgamstop.orgBetimgrandpashabet girişhttps://na-samom-dele.ru/казино водкаhttps://monteon.ru/seo ajansıyurtdışı turseo danışmanlığıjojobetviagra 100 mg fiyat